The French neurodegenerative diseases roadmap 2021-2022 was officially launched on 1 June 2021. The associations which are stakeholders of this road map and worked with the French Ministry of Health to build it, acknowledge this essential step, as the country’s former neurodegenerative diseases plan (PMND) ended more than a year ago. They remain cautious, however, and demand strong commitments from the French Government on the dedicated budget (still unknown), the deployment schedule and the continuous assessment of the different measures.
Indeed, the roadmap has been introduced as a work plan “not intended to cover the entire scope of measures necessary to meet the needs of people living with neurodegenerative diseases. It is targeted on the measures of the former PMND for which the non-completion or the need for appropriation requires that the efforts be continued”. This is not ambitious enough for France Alzheimer, which asks for a strong, long-term commitment from the Government to address this major public health issue and allow concrete improvements for people living with dementia and their carers.
